# A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin

> **NCT01411111** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Rosuvastatin 10 mg
- **DRUG:** GSK2190915 30mg
- **DRUG:** GSK2190915 100mg

## Key facts

- **NCT ID:** NCT01411111
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-06
- **Primary completion:** 2011-02-23
- **Final completion:** 2011-02-23
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01411111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01411111, "A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01411111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*